Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 386841 - 386860 out of 498375 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Saudi Arabia | (J05AX31) lenacapavir (adm: O) | SUNLENCA | 5 Blister, 300 mg, Oral use, Film-coated tablet, 300mg , Blister, Film-coated tablet | Retail price without vat |
$0-0 |
$0-0 |
HIV Infections | GileadSciences,Inc / ROTTENDORFPHARMAGMBH |
| Saudi Arabia | (J05AX31) lenacapavir (adm: P) | SUNLENCA 463.5 mg per 1.5 ml | 2 Vial, 1,5ml, 309 mg, Subcutaneous use, Solution for injection, 309mg , Vial, Solution for injection | Retail price without vat |
$0-0 |
$0-0 |
HIV Infections | GileadSciences,Inc / PatheonItaliaS.P.A. |
| Saudi Arabia | (J06BA01) immunoglobulins, normal human, for extravascular adm. | CUVITRU 200MG/ML INJECTION | 1 Vial, 5ml, 200 mg/ml, Subcutaneous use, Solution for injection, 200mg/ml , Vial, Solution for injection | Retail price without vat |
$0-0 |
$0-0 |
n/a | BaxaltaInnovationsGmbH / BaxaltaBelgiumManufacturingSA |
| Saudi Arabia | (J06BA01) immunoglobulins, normal human, for extravascular adm. | CUVITRU 200MG/ML INJECTION | 1 Vial, 10ml, 200 mg/ml, Subcutaneous use, Solution for injection, 200mg/ml , Vial, Solution for injection | Retail price without vat |
$0-0 |
$0-0 |
n/a | BaxaltaInnovationsGmbH / BaxaltaBelgiumManufacturingSA |
| Saudi Arabia | (J06BA01) immunoglobulins, normal human, for extravascular adm. | CUVITRU 200MG/ML INJECTION | 1 Vial, 20ml, 200 mg/ml, Subcutaneous use, Solution for injection, 200mg/ml , Vial, Solution for injection | Retail price without vat |
$0-0 |
$0-0 |
n/a | BaxaltaInnovationsGmbH / BaxaltaBelgiumManufacturingSA |
| Saudi Arabia | (J06BA01) immunoglobulins, normal human, for extravascular adm. | CUVITRU 200MG/ML INJECTION | 1 Vial, 40ml, 200 mg/ml, Subcutaneous use, Solution for injection, 200mg/ml , Vial, Solution for injection | Retail price without vat |
$0-0 |
$0-0 |
n/a | BaxaltaInnovationsGmbH / BaxaltaBelgiumManufacturingSA |
| Saudi Arabia | (J07AH08) meningococcus a,c,y,w-135, tetravalent purified polysaccharides antigen conjugated | MENVEO VACCINE | 1 Vial, 10,5,5,5 Intramuscular use, Powder and solution for solution for injection, 10,5,5,5 , Vial, Powder and solution for solution for injection | Retail price without vat |
$0-0 |
$0-0 |
Immunization; Meningitis, Meningococcal | GlaxoSaudiArabiaLtd. / GSKVaccinesSrl |
| Saudi Arabia | (J07BC02) hepatitis a, inactivated, whole virus | VAQTA 25U SYRINGE I.M | 1 Pre-filled syringe, 25 U, Intramuscular use, Suspension for injection in pre-filled syringe, 25U , Pre-filled syringe, Suspension for injection in pre-filled syringe | Retail price without vat |
$0-0 |
$0-0 |
n/a | MERCKSHARP&DOHME / MERCKSHARPANDDOHMELLC |
| Saudi Arabia | (J07BD52) measles, combinations with mumps and rubella, live attenuated | PRIORIX 0.5ML VIAL | 1 Vial, 5011.87,1000,1000 Intramuscular use, Solution for injection, 5011.87,1000,1000 , Vial, Solution for injection | Retail price without vat |
$0-0 |
$0-0 |
n/a | GLAXOSAUDIARABIA / GLAXOSMITHKLINE(GSK) |
| Saudi Arabia | (L01AX03) temozolomide | TEGOZOL 100 mg Capsule | 5 Bottle, 100 mg, Oral use, Capsule, 100mg , Bottle, Capsule | Retail price without vat |
$0-0 |
$0-0 |
n/a | JazeeraPharmaceuticalIndustries(JPI) / TheArabPharmaceuticalManufacturingPSC(Sahab)CoLtd |
| Saudi Arabia | (L01AX03) temozolomide | TEGOZOL 20 mg Capsule | 5 Bottle, 20 mg, Oral use, Capsule, 20mg , Bottle, Capsule | Retail price without vat |
$0-0 |
$0-0 |
n/a | JazeeraPharmaceuticalIndustries(JPI) / TheArabPharmaceuticalManufacturingPSC(Sahab)CoLtd |
| Saudi Arabia | (L01AX03) temozolomide | TEGOZOL 250 mg Capsule | 5 Bottle, 250 mg, Oral use, Capsule, 250mg , Bottle, Capsule | Retail price without vat |
$0-0 |
$0-0 |
n/a | JazeeraPharmaceuticalIndustries(JPI) / TheArabPharmaceuticalManufacturingPSC(Sahab)CoLtd |
| Saudi Arabia | (L01BA01) methotrexate | METHOTREXATE 1G-10ML INJ.FOR I.V OR I.M | 1 Vial, 10ml, 100 mg/ml, Intravenous use, Solution for injection, 100mg/ml , Vial, Solution for injection | Retail price without vat |
$0-0 |
$0-0 |
n/a | HOSPIRAUKLIMITED / HOSPIRAAUSTRALIA |
| Saudi Arabia | (L01BC06) capecitabine | DIROGIT 500 MG F. C. TABLET | 120 Blister, 500 mg, Oral use, Film-coated tablet, 500mg , Blister, Film-coated tablet | Retail price without vat |
$0-0 |
$0-0 |
n/a | JazeeraPharmaceuticalIndustries(JPI) / TheArabPharmaceuticalManufacturingPSC(Sahab)CoLtd |
| Saudi Arabia | (L01BC59) trifluridine, combinations | Trumavar | 20 Blister, 15,6.14 mg, Oral use, Film-coated tablet, 15,6.14mg , Blister, Film-coated tablet | Retail price without vat |
$0-0 |
$0-0 |
n/a | BostonOncologyArabia / NatcoPharmaLimited |
| Saudi Arabia | (L01BC59) trifluridine, combinations | Trumavar | 20 Blister, 20,8.19 mg, Oral use, Film-coated tablet, 20,8.19mg , Blister, Film-coated tablet | Retail price without vat |
$0-0 |
$0-0 |
n/a | BostonOncologyArabia / NatcoPharmaLimited |
| Saudi Arabia | (L01EA02) dasatinib (adm: O) | Otrasa | 30 Blister, 100 mg, Oral use, Film-coated tablet, 100mg , Blister, Film-coated tablet | Retail price without vat |
$0-0 |
$0-0 |
n/a | SUDAIRPHARMACOMPANY / SudairPharmaCompany |
| Saudi Arabia | (L01EA02) dasatinib (adm: O) | Otrasa | 60 Blister, 50 mg, Oral use, Film-coated tablet, 50mg , Blister, Film-coated tablet | Retail price without vat |
$0-0 |
$0-0 |
n/a | SUDAIRPHARMACOMPANY / SudairPharmaCompany |
| Saudi Arabia | (L01EC02) dabrafenib (adm: O) | TAFINLAR 50MG CAPSULE(28) | 28 Bottle, 50 mg, Oral use, Capsule, hard, 50mg , Bottle, Capsule, hard | Retail price without vat |
$0-0 |
$0-0 |
Melanoma | NOVARTISPHARMASCHWEIZAG / GlaxoOperationsUKLimited |
| Saudi Arabia | (L01EC02) dabrafenib (adm: O) | TAFINLAR 75MG CAPSULE(28) | 28 Bottle, 75 mg, Oral use, Capsule, hard, 75mg , Bottle, Capsule, hard | Retail price without vat |
$0-0 |
$0-0 |
Melanoma | NOVARTISPHARMASCHWEIZAG / GlaxoOperationsUKLimited |
Pages
